Literature DB >> 25645107

Locoregional recurrences after post-operative volumetric modulated arc radiotherapy (VMAT) in oral cavity cancers in a resource constrained setting: experience and lessons learned.

S Chakraborty1, V M Patil, S Babu, G Muttath, S K Thiagarajan.   

Abstract

OBJECTIVE: The conformal nature of dose distribution produced by volumetric modulated arc radiotherapy (VMAT) increases the risk of geographic miss. Data regarding patterns of failure after VMAT in oral cavity cancers in resource-constrained settings are scarce. The aim of the present study was to ascertain the patterns of failure in patients receiving adjuvant VMAT intensity-modulated radiotherapy (IMRT) for oral cavity cancer in Malabar Cancer Center, Kerala, India.
METHODS: Data of patients with oral cavity cancer receiving adjuvant VMAT IMRT between April 2012 and March 2014 were collected. Recurrent volumes were delineated on the treatment planning images and classified as defined by Dawson et al (Dawson LA, Anzai Y, Marsh L, Martel MK, Paulino A, Ship JA, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2000; 46: 1117-26).
RESULTS: 75 patients with a median follow-up of 24 months were analysed. 41 (55%) patients had oral tongue cancers and 52 (69%) of the patients had Stage IVA cancers. The 2-year locoregional recurrence-free survival, disease-free survival and overall survival were 88.9%, 82.1% and 80.5%, respectively. With a median time to failure of 6.5 months, five infield and three outfield failures were identified.
CONCLUSION: A relatively low rate of outfield failure and lack of marginal failure attests to the efficacy of VMAT in such patients. Modifications to our existing target delineation policy have been proposed. ADVANCES IN KNOWLEDGE: The use of standardized target delineation methods allows safe use of VMAT IMRT even in resource-constrained settings.

Entities:  

Mesh:

Year:  2015        PMID: 25645107      PMCID: PMC4651253          DOI: 10.1259/bjr.20140795

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  28 in total

1.  Intensity-modulated radiotherapy for oral cavity squamous cell carcinoma: patterns of failure and predictors of local control.

Authors:  Megan E Daly; Quynh-Thu Le; Margaret M Kozak; Peter G Maxim; James D Murphy; Annie Hsu; Billy W Loo; Michael J Kaplan; Nancy J Fischbein; Daniel T Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-02       Impact factor: 7.038

2.  Increased recurrences using intensity-modulated radiation therapy in the postoperative setting.

Authors:  Aruna Turaka; Tianyu Li; Navesh K Sharma; Linna Li; Nicos Nicolaou; Ranee Mehra; Barbara Burtness; Roger B Cohen; Miriam N Lango; Eric M Horwitz; John A Ridge; Steven J Feigenberg
Journal:  Am J Clin Oncol       Date:  2010-12       Impact factor: 2.339

3.  Marginal recurrences after selective targeting with intensity-modulated radiotherapy for oral tongue cancer.

Authors:  Shari Damast; Suzanne Wolden; Nancy Lee
Journal:  Head Neck       Date:  2011-01-31       Impact factor: 3.147

4.  Response to letter to the editor with reference to article "Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure".

Authors:  Andrew K Chan; Shao Hui Huang; Lisa W Le; Eugene Yu; Laura A Dawson; John J Kim; B C John Cho; Andrew J Bayley; Jolie Ringash; David Goldstein; Kelvin Chan; John Waldron; Brian O'Sullivan; Bernard Cummings; Andrew J Hope
Journal:  Oral Oncol       Date:  2013-03-09       Impact factor: 5.337

5.  Clinical audit in radiation oncology: results from one academic centre in Delhi, India.

Authors:  Jaspreet Kaur; Bidhu Kalyan Mohanti; Sandeep Muzumder
Journal:  Asian Pac J Cancer Prev       Date:  2013

6.  Outcomes of postoperative simultaneous modulated accelerated radiotherapy for head-and-neck squamous cell carcinoma.

Authors:  Sung Ho Moon; Yuh-Seog Jung; Jun Sun Ryu; Sung Weon Choi; Joo Yong Park; Tak Yun; Sang Hyun Lee; Kwan Ho Cho
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-21       Impact factor: 7.038

7.  Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy.

Authors:  David J Sher; Vijaya Thotakura; Tracy A Balboni; Charles M Norris; Robert I Haddad; Marshall R Posner; Jochen Lorch; Laura A Goguen; Donald J Annino; Roy B Tishler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-29       Impact factor: 7.038

8.  Follow up after IMRT in oral cavity cancer: update.

Authors:  Gabriela Studer; Michelle Brown; Marius Bredell; Klaus W Graetz; Gerhard Huber; Claudia Linsenmeier; Yousef Najafi; Oliver Riesterer; Tamara Rordorf; Stephan Schmid; Christoph Glanzmann
Journal:  Radiat Oncol       Date:  2012-06-11       Impact factor: 3.481

9.  Image-guided intensity modulated radiotherapy with helical tomotherapy for postoperative treatment of high-risk oral cavity cancer.

Authors:  Chen-Hsi Hsieh; Ying-Shiung Kuo; Li-Jen Liao; Kawang-Yu Hu; Shih-Chiang Lin; Le-Jung Wu; Yu-Chin Lin; Yu-Jen Chen; Li-Ying Wang; Yen-Ping Hsieh; Shoei Long Lin; Chun-Yi Chen; Chien-An Chen; Pei-Wei Shueng
Journal:  BMC Cancer       Date:  2011-01-27       Impact factor: 4.430

10.  Outcome and patterns of failure after postoperative intensity modulated radiotherapy for locally advanced or high-risk oral cavity squamous cell carcinoma.

Authors:  Andreas Geretschläger; Beat Bojaxhiu; Susanne Crowe; Andreas Arnold; Peter Manser; Wock Hallermann; Daniel M Aebersold; Pirus Ghadjar
Journal:  Radiat Oncol       Date:  2012-10-22       Impact factor: 3.481

View more
  2 in total

1.  Definitive-intent intensity-modulated radiation therapy provides similar outcomes to those previously published for definitive-intent three-dimensional conformal radiation therapy in dogs with primary brain tumors: A multi-institutional retrospective study.

Authors:  Nathaniel Van Asselt; Neil Christensen; Valeria Meier; Carla Rohrer Bley; Sarah Laliberte; Valerie J Poirier; Noopur Desai; Yi Chen; Michelle Turek
Journal:  Vet Radiol Ultrasound       Date:  2020-05-01       Impact factor: 1.363

2.  The Hippocampus: A New Organ at Risk for Postoperative Radiation Therapy for Bucco-alveolar Cancer? A Dosimetric and Biological Analysis.

Authors:  Sapna Nangia; Maneesh Singh; Robin Khosa; Sanjay Kumar Rout; Grishma Singh; Saji Oomen
Journal:  Adv Radiat Oncol       Date:  2021-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.